These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

135 related articles for article (PubMed ID: 21246777)

  • 21. Myocardial protection at a crossroads: the need for translation into clinical therapy.
    Bolli R; Becker L; Gross G; Mentzer R; Balshaw D; Lathrop DA;
    Circ Res; 2004 Jul; 95(2):125-34. PubMed ID: 15271864
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of growth hormone in chronic heart failure: therapeutic implications.
    Volterrani M; Giustina A; Manelli F; Cicoira MA; Lorusso R; Giordano A
    Ital Heart J; 2000 Nov; 1(11):732-8. PubMed ID: 11110515
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pharmacogenetics of multigenic disease: heart disease as an example.
    Cooke GE
    Vascul Pharmacol; 2006 Feb; 44(2):66-74. PubMed ID: 16376619
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Cancer Drug Development: New Targets for Cancer Treatment.
    Curt GA
    Oncologist; 1996; 1(3):II-III. PubMed ID: 10387987
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The future of 'pure' medical science: the need for a new specialist professional research system.
    Charlton BG; Andras P
    Med Hypotheses; 2005; 65(3):419-25. PubMed ID: 15985341
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Differential gene expression profiling in genetic and multifactorial cardiovascular diseases.
    Nanni L; Romualdi C; Maseri A; Lanfranchi G
    J Mol Cell Cardiol; 2006 Dec; 41(6):934-48. PubMed ID: 17020763
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Modern therapy of cardiac insufficiency].
    Stojsić D; Jelkić N
    Med Pregl; 1999; 52(3-5):113-24. PubMed ID: 10518395
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Cancer genomics object model: an object model for multiple functional genomics data for cancer research.
    Park YR; Lee HW; Cho SB; Kim JH
    Stud Health Technol Inform; 2007; 129(Pt 2):1235-9. PubMed ID: 17911912
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Burning questions in heart failure management: why do surgeons and interventional cardiologists talk of regenerative cell therapy?
    Sherman W; Cho C; Martens TP
    Heart Fail Clin; 2007 Apr; 3(2):245-52. PubMed ID: 17643925
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The emerging field of lipidomics.
    Wenk MR
    Nat Rev Drug Discov; 2005 Jul; 4(7):594-610. PubMed ID: 16052242
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Urinary proteomics--a tool for biomarker discovery.
    Pejcic M; Stojnev S; Stefanovic V
    Ren Fail; 2010 Jan; 32(2):259-68. PubMed ID: 20199189
    [TBL] [Abstract][Full Text] [Related]  

  • 32. The reduction of infarct size--forty years of research.
    Ferreira R
    Rev Port Cardiol; 2010 Jun; 29(6):1037-53. PubMed ID: 20964114
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Mass spectrometry-based proteomics in biomedical research: emerging technologies and future strategies.
    Walsh GM; Rogalski JC; Klockenbusch C; Kast J
    Expert Rev Mol Med; 2010 Sep; 12():e30. PubMed ID: 20860882
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Clinical trials and personalized medicine in oncology?].
    Arnold D; Bokemeyer C
    Onkologie; 2010; 33 Suppl 7():25-9. PubMed ID: 20926911
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Recent progress in biomolecular engineering.
    Ryu DD; Nam DH
    Biotechnol Prog; 2000; 16(1):2-16. PubMed ID: 10662483
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Beware the Medical-Industrial Complex.
    Stevens CW; Glatstein E
    Oncologist; 1996; 1(4):IV-V. PubMed ID: 10388005
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Role of oncoproteomics in the personalized management of cancer.
    Jain KK
    Expert Rev Proteomics; 2004 Jun; 1(1):49-55. PubMed ID: 15966798
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Personalized medicine in oncology: tailoring the right drug to the right patient.
    Jiang Y; Wang M
    Biomark Med; 2010 Aug; 4(4):523-33. PubMed ID: 20701441
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Heart failure in the post-genomics era: gene-environment interactions.
    Arab S; Liu PP
    Curr Opin Mol Ther; 2005 Dec; 7(6):577-82. PubMed ID: 16370381
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Myocardial gene therapy.
    Isner JM
    Nature; 2002 Jan; 415(6868):234-9. PubMed ID: 11805848
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.